Loading the session
Loading the session
Loading instrument
$29.80
+9.68%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:47 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 close of $27.17 was 20.4% above its 50-day average ($22.57) and 14.8% above its 200-day average ($23.68). It has closed above the 200-day for 7 sessions, since 27 Oct 2026. The 50-day average crossed below the 200-day on 22 Sep 2026, 31 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: +22.7% (SPY −1.6%, XLV +13.5%). 3 months: +18.9% (SPY −0.4%, XLV +15.5%). 1 year: +7.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: STAA, SPY and XLV · as of 4 Nov 2026
3.7M shares were sold short at the 15 Oct 2026 settlement, 7.4% of the 50.1M shares outstanding; covering them would take 6.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 14-session relative strength index closed at 72.8 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Closed at $27.17 on 4 Nov 2026: 24.3% below the 52-week high of $35.87 (14 May 2026) and 74.3% above the low of $15.59 (17 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
April 9, 2026
+20.74%August 5, 2025
+46.13%February 12, 2025
−24.68%